Follow

Pharmacolog i Uppsala AB

Nasdaq First North GM Stockholm (Sweden)

Pharmacolog i Uppsala develops systems and solutions that aim to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog, DrugLog, and PrepLog, which are aimed at a large number of treatment areas, such as; oncology, infectious diseases, and intensive care.
Go to market

Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Media
Exercise
Price
0.60-7.50 SEK
Exercise period(s)
04 Oct - 18 Oct 2023
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
PHLOG B
SE0019071812
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Pharmacolog i Uppsala AB with ticker PHLOG B
Status
Active
Currency
SEK
First trading date
08 Jun 2015
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
PHLOG TO2 B
SE0018537839
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Pharmacolog i Uppsala AB with ticker PHLOG TO2 B
Status
Active
Currency
SEK
Trading period
18 Oct 2022 - 13 Oct 2023
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period September 19, 2023 - October 2, 2023, however, not less than SEK 0.6 (share quota value) and not more than SEK 7.50 per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
PHLOG TO3 B
SE0020539864
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Pharmacolog i Uppsala AB with ticker PHLOG TO3 B
Status
Active
Currency
SEK
Trading period
07 Aug 2023 - 20 Feb 2024
Terms
Each warrant of series TO3 gives the right to subscribe for one (1) new share of series B in the Company. The subscription price for the subscription of shares through the exercise of warrants of series TO3 amounts to 70 percent of the volume-weighted average price for the Company's share during the period from and including 25 January 2024 to and including 7 February 2024, however the lowest the share's quota value and the highest SEK 0.53. The warrants can be used to subscribe for new shares during the period from and including 9 February 2024 to and including 23 February 2024.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
PHLOG
SE0006732020
Spotlight Stock Market
Sweden (SE)
Details of share in Pharmacolog i Uppsala AB with ticker PHLOG
Status
Archived
Currency
SEK
First trading date
08 Jun 2015
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
PHLOG B
SE0011178763
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Pharmacolog i Uppsala AB with ticker PHLOG B
Status
Archived
Currency
SEK
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
PHLOG B
SE0019071812
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Pharmacolog i Uppsala AB with ticker PHLOG B
Status
Active
Currency
SEK
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
PHLOG TO1 B
SE0014609012
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Pharmacolog i Uppsala AB with ticker PHLOG TO1 B
Status
Archived
Currency
SEK
Trading period
28 Jul 2020 - 13 Aug 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period July 26, 2021 - August 6, 2021, however, not less than share quota value and not more than SEK 12.0 per share.
Update (06.08.2021): Exercise price has been set - SEK 8.06.
Update (12.08.2021): Last trading day for warrants TO1 B is August 13, 2021.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
PHLOG TO2 B
SE0018537839
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Pharmacolog i Uppsala AB with ticker PHLOG TO2 B
Status
Active
Currency
SEK
Trading period
18 Oct 2022 - 13 Oct 2023
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period September 19, 2023 - October 2, 2023, however, not less than SEK 0.6 (share quota value) and not more than SEK 7.50 per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
PHLOG TO3 B
SE0020539864
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Pharmacolog i Uppsala AB with ticker PHLOG TO3 B
Status
Active
Currency
SEK
Trading period
07 Aug 2023 - 20 Feb 2024
Terms
Each warrant of series TO3 gives the right to subscribe for one (1) new share of series B in the Company. The subscription price for the subscription of shares through the exercise of warrants of series TO3 amounts to 70 percent of the volume-weighted average price for the Company's share during the period from and including 25 January 2024 to and including 7 February 2024, however the lowest the share's quota value and the highest SEK 0.53. The warrants can be used to subscribe for new shares during the period from and including 9 February 2024 to and including 23 February 2024.
Exercise
Sign in to buy
People
Lars Gusch
CEO
Erik Hedlund
Chairman of the board
Carl-Johan Spak
Board member
Ragnar Linder
Board member
Olle Johansson
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Ekeby Bruk 2H
Zip code
752 63
City/district
Uppsala
Country
Sweden (SE)
Registration number
556723-6418
LEI code
549300DLW63ZHWJPCF27
First trade date
08 Jun 2015
Registration date
14 Feb 2007
Short name
PHLOG

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More